Stay updated on Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T07:40:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T07:42:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The record for the teplizumab trial in children and adolescents with newly diagnosed type 1 diabetes is replaced by a 403 Forbidden error page, so its study details and results are no longer displayed.
    Difference
    19%
    Check dated 2026-10-05T08:17:06.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error indicating restricted access to the study record. The addition includes the literal 403, the HTML doctype and '403 Forbidden' header text, and a Home link, reflecting a blocked-access state rather than the study content.
    Difference
    0.5%
    Check dated 2026-09-28T08:48:37.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and blocks access to the study details, showing an access-denied message.
    Difference
    19%
    Check dated 2026-09-21T01:22:00.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a version update to the study details page. This update likely contains minor fixes or changes to the page layout or metadata without altering the study data or its interpretation.
    Difference
    0.0%
    Check dated 2026-08-30T22:43:23.000Z thumbnail image

Stay in the know with updates to Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.